Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of 5% dapsone gel in the treatment of acne vulgaris
IRCT20230806059062N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dapsone in acne vulgaris, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20230806059062N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230806059062N1.